Health Care & Life Sciences » Pharmaceuticals | Easton Pharmaceuticals Inc.

Easton Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
67.40
-
-
153.00
378.60
Cost of Goods Sold (COGS) incl. D&A
-
43.60
-
-
-
271.70
Gross Income
-
23.80
-
-
153.00
106.90
SG&A Expense
341.80
478.90
638.60
115.00
98.10
231.10
EBIT
341.80
455.10
638.60
-
54.90
124.20
Non Operating Income/Expense
4.80
94.30
38.60
-
300.20
-
Pretax Income
346.50
360.80
599.90
872.80
245.30
169.20
Consolidated Net Income
346.50
360.80
599.90
872.80
245.30
169.20
Net Income
346.50
360.80
599.90
872.80
245.30
169.20
Net Income After Extraordinaries
346.50
360.80
599.90
872.80
245.30
169.20
Net Income Available to Common
346.50
360.80
599.90
872.80
245.30
169.20
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
-
Basic Shares Outstanding
243,763.00
535,498.00
928,489.40
932,728.60
932,728.60
1,211,395.20
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
-
Diluted Shares Outstanding
243,763.00
535,498.00
928,489.40
932,728.60
932,728.60
1,211,395.20
EBITDA
341.80
455.10
638.60
115.00
54.90
-
Non-Operating Interest Income
-
-
-
44.00
-
-

About Easton Pharmaceuticals

View Profile
Address
650 Bay Street
Toronto Ontario M5G 1M8
Canada
Employees -
Website http://www.eastonpharmaceuticalsinc.com
Updated 07/08/2019
Easton Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. The company was founded by John K.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.